These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 2275164)
1. [The dynamics of lipid peroxidation in patients with ischemic heart disease and hypertension during anaprilin treatment]. Koryt'ko IN Vrach Delo; 1990 Apr; (4):43-5. PubMed ID: 2275164 [TBL] [Abstract][Full Text] [Related]
2. [The lipid peroxidation indices of hypertension patients undergoing combined therapy with anaprilin, korinfar and hypothiazide]. Iarema NI; Rudyk BI Ter Arkh; 1995; 67(8):28-30. PubMed ID: 7482327 [TBL] [Abstract][Full Text] [Related]
3. [A comparative study of the membrane-protector efficacy of anaprilin and korinfar in hypertension patients]. Gapon LI; Kremneva LV; Abaturova OV Lik Sprava; 1996; (10-12):69-71. PubMed ID: 9138819 [TBL] [Abstract][Full Text] [Related]
4. [The function of membrane Ca-ATPases and nonenzymatic peroxidation of membrane lipids in patients with hypertension]. Siurin AA; Kulagin IuI; Anikin EI; Prokhoda AF; Kabeliuzhenko SB; Shcherbina LI Vopr Med Khim; 1990; 36(3):69-71. PubMed ID: 2143337 [TBL] [Abstract][Full Text] [Related]
5. [Lipid peroxidation in patients with hypertension and chronic pyelonephritis with arterial hypertension]. Siurin AA; Kulagin IuI; Kuznetsov NS; Prokhoda AF; Gets NP; Vyborova VA Klin Med (Mosk); 1990 Dec; 68(12):20-2. PubMed ID: 2084329 [TBL] [Abstract][Full Text] [Related]
6. [The effect of parmidine on the lipid peroxidation processes in coronary atherosclerosis]. Artem'eva GB; Rakita DR; Uzbekova DG; Garbash VIa Farmakol Toksikol; 1990; 53(4):56-8. PubMed ID: 2226764 [TBL] [Abstract][Full Text] [Related]
7. [The effect of korinfar and anaprilin on lipid peroxidation and the antioxidant system in hypertension patients]. Iarema NI Lik Sprava; 1992 Jun; (6):101-3. PubMed ID: 1455812 [TBL] [Abstract][Full Text] [Related]
8. [Clinical-metabolic evaluation of the effectiveness of the olive oil use in patients with cardiovascular diseases]. Pogozheva AV; Pokrovskaia GR; Kulakova SN; Trushina EN; Levachev MM Vopr Pitan; 2000; 69(1-2):41-3. PubMed ID: 10943005 [TBL] [Abstract][Full Text] [Related]
9. [The effect of propranolol on the apoprotein spectrum of the blood plasma in patients with ischemic heart disease]. Mikhin VP; Shuliak LN; Kameneva AM Vrach Delo; 1990 Feb; (2):24-6. PubMed ID: 2339543 [TBL] [Abstract][Full Text] [Related]
10. [Comparative evaluation of the effect of anaprilin, isoptin and labetalol on the peripheral circulation of hypertension patients]. Vilkovyskiĭ FA; Zaslavskaia RM; Olevskiĭ IKh; Varshitskiĭ MG; Teĭblium MM Farmakol Toksikol; 1988; 51(1):62-6. PubMed ID: 3360111 [TBL] [Abstract][Full Text] [Related]
11. [Lipid peroxidation and change in the lipid fraction of plasma in patients with hypertonic disease]. Siurin AA; Kobozev GV; Kulagin IuI; Safronova LG; Anikin EI; Kabeliuzhenko SB; Skorobatskiĭ VS Vopr Med Khim; 1991; 37(2):26-8. PubMed ID: 1897186 [TBL] [Abstract][Full Text] [Related]
12. [The role of lipid peroxidation in cell membranes in the pathogenesis of hypertension]. Siurin AA; Kulagin IuI Sov Med; 1987; (11):62-5. PubMed ID: 3445153 [No Abstract] [Full Text] [Related]
14. [Clinico-biochemical parallels against a background of traditional treatment and laser therapy of patients with ischemic heart disease]. Korochkin IM; Kartelishev AV; Leshakov SIu; Kapustina GM; Vernekina NS Ter Arkh; 1988; 60(12):40-4. PubMed ID: 3247652 [TBL] [Abstract][Full Text] [Related]
15. [Hemodynamic assessment of anti-angina preparations in treating patients with ischemic heart disease with hypertension]. Iunusov RA; Burykh LN; Sviridova NI Vrach Delo; 1987 Aug; (8):25-7. PubMed ID: 3686955 [No Abstract] [Full Text] [Related]
16. [The activity of the antioxidant system and membrane lipid peroxidation in hypertension patients]. Polivoda SN; Shershnev VG Lik Sprava; 1993 Jul; (7):60-3. PubMed ID: 8209536 [TBL] [Abstract][Full Text] [Related]
17. [Essential phospholipids in the treatment of chronic pyelonephritis]. Ovchinnikov AA; Tsvettsikh VE; Berdichevskiĭ BA; Lykov VN; Suktanbaev VR; Murychev AV Urol Nefrol (Mosk); 1996; (4):7-9. PubMed ID: 8928353 [TBL] [Abstract][Full Text] [Related]
18. [The hypotensive action of anaprilin in hypertension]. Andrushchenko EV; Rubaĭ IN Vrach Delo; 1989 Mar; (3):32-4. PubMed ID: 2750114 [TBL] [Abstract][Full Text] [Related]
19. [Clinical efficacy of combined therapy with enalapril + trimetazidine in patients with hypertension comorbid with ischemic heart disease and metabolic disturbances]. Petelina TI; Gapon LI; Bakhmatova IuA; Zhevagina IA Ter Arkh; 2005; 77(8):19-23. PubMed ID: 16206600 [TBL] [Abstract][Full Text] [Related]
20. [Lipid peroxidation and erythrocyte membrane function in congenital heart defects in relation to the use of beta-adrenoblockers]. Minkov IP Lik Sprava; 1992 Aug; (8):21-4. PubMed ID: 1362025 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]